Rebif New Formulation (RNF) Quality of Life (QOL) Study

PHASE3CompletedINTERVENTIONAL

Enrollment

232

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

November 30, 2009

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG

Rebif New Formulation Non Titrated

human interferon beta 1a - Rebif New Formulation

DRUG

Rebif New Formulation Titrated

Human interferon beta 1a Rebif New Formulation

Trial Locations (1)

EMD Serono, Inc., Rockland